MARATTO

article · Journal of Experimental Pharmacology

Acute and Sub-Acute Toxicity Evaluation of the Crude Methanolic Extract of Justicia schimperiana Leaf in Wistar Albino Rats

202327 citationsOpen accessDebre Tabor University

In plain language

This study evaluates the acute and sub-acute toxicity of an 80 percent methanolic leaf extract of Justicia schimperiana in Wistar albino rats following international testing guidelines. Acute exposure via a single oral dose of 5000 milligrams per kilogram produced no fatalities or significant morbidity, indicating a median lethal dose exceeding this threshold. In a 28-day sub-acute trial, rats received daily doses of 250, 500, or 1000 milligrams per kilogram. The treatment did not adversely influence general behaviour, food consumption, organ weights, or biochemical parameters, although rats receiving the highest dose showed reductions in haemoglobin and haematocrit levels. Animals across all treatment groups gained body weight, and examination of tissues revealed only minor histological alterations in a few organs. Overall, oral administration of the crude extract was found to be relatively safe under the tested conditions.

Key takeaways

  • A single oral dose of 5000 mg/kg of Justicia schimperiana leaf extract caused no deaths or severe morbidity, indicating a median lethal dose greater than 5000 mg/kg.
  • Daily oral doses up to 1000 mg/kg over 28 days did not significantly alter animal behaviour, food intake, organ weights, or biochemical markers.
  • Rats treated with the highest dose of 1000 mg/kg exhibited reductions in haemoglobin and haematocrit.
  • The crude leaf extract was concluded to be relatively safe following acute and 28-day repeated oral administration in rats.

Why it matters

Safety profiling is essential when assessing traditional medicinal plants for wider therapeutic use. Determining the acute and repeated-dose toxicity thresholds of Justicia schimperiana leaves in standard animal models helps establish baseline safety data. This evidence provides researchers with necessary toxicity boundaries, highlighting safe dosage limits and identifying potential impacts on blood parameters such as haemoglobin levels.

Commercialisation angle

This research represents very early-stage safety validation for crude extracts of Justicia schimperiana. Pharmaceutical researchers and developers exploring medicinal plant formulations could use these baseline toxicity findings to guide safe dosage parameters in further preclinical evaluations. Substantial additional work, including active compound isolation, efficacy testing, and advanced safety trials, remains necessary before any commercial product or therapeutic application can be pursued.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Purpose: This study evaluates the acute and sub-acute toxicity of 80% methanolic extracts of the leaves of Justicia schimperiana in Wistar albino rat models. Methods: Dried powdered leaves of Justicia schimperiana were macerated in 80% methanol. The experiment was conducted in accordance with the Organization for Economic Co-operation and Development guideline 423 for acute and 407 for sub-acute toxicity testing. A single dose of 5000 mg/kg extract was orally administered to three female rats for the acute toxicity study. The plant extract was administered orally for 28 days in daily dosages of 250, 500, and 1000 mg/kg for the sub-acute study. Animals in a control group were given distilled water. A total of 40 rats (5 rats/group/sex) were used for the sub-acute toxicity testing. Daily food intake and weekly body weight measurements were done. The rats were sacrificed at the end of the 28-day treatment period for hematological, biochemical, and histopathological tests. One-way analysis of variance and Kruskal–Wallis tests were employed for the analysis. Results: The single-dose oral administration of the plant resulted in no deaths or serious morbidity. The median lethal dose was > 5000 mg/kg. The 28-day oral treatment of the plant extract had no significant effect on general behavior, food intake, organ weight, biochemical parameters, or the majority of the hematological markers, with the exception of the decrease in hemoglobin and hematocrit in the 1000 mg/kg extract-treated groups compared to the controls. Both sexes experienced significant weight increases at all dosage levels. With the exception of minor alterations in a few of the organs, no significant histological change was identified. Conclusion: It is concluded that the single-dose and repeated-dose 28-day oral administration of the methanolic leaf extract of Justicia schimperiana is relatively safe. Keywords: acute toxicity, sub-acute toxicity, Justicia schimperiana , rats, crude extract

Research topics

  • Drug-Induced Hepatotoxicity and Protection
  • Ethnobotanical and Medicinal Plants Studies
  • Andrographolide Research and Applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2147/jep.s441273

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.